Showing results (391-400 of 638) with videos related to
Sort By:
Pageof 64
Journal of Cell Science|July 1, 1994
Sites in human nuclei where damage induced by ultraviolet light is repaired: localization relative to transcription sites and concentrations of proliferating cell nuclear antigen and the tumour suppressor protein, p53D A Jackson, A B Hassan, R J Errington, et al.Cell Death & Disease|May 20, 2011
Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1A Ahmed, J Yang, A Maya-Mendoza, et al.British Journal of Clinical Pharmacology|July 25, 2000
Constriction to ETB receptor agonists, BQ-3020 and sarafotoxin s6c, in human resistance and capacitance vessels in vivoF E Strachan, T R Crockett, N L Mills, et al.Scottish Medical Journal|March 12, 2004
Physician opinions on the implementation of the SIGN guideline for heart failureS P McKee, S J Leslie, J P LeMaitre, et al.Circulation|November 1, 1996
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitorsM P Love, W G Haynes, G A Gray, et al.Kidney International|September 1, 1995
Erythropoietin enhances vascular responsiveness to norepinephrine in renal failureM F Hand, W G Haynes, H A Johnstone, et al.Journal of the American College of Cardiology|June 17, 1998
Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome XD E Newby, L L Flint, K A Fox, et al.Scottish Medical Journal|January 12, 2000
Effect of cold exposure, exercise and high altitude on plasma endothelin-1 and endothelial cell markers in manN L Cruden, D E Newby, J A Ross, et al.Heart (British Cardiac Society)|January 20, 2004
Hyperuricaemia does not impair cardiovascular function in healthy adultsW S Waring, S H Adwani, O Breukels, et al.British Journal of Pharmacology|January 10, 1998
Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drugI L Megson, I R Greig, G A Gray, et al.Pageof 64